Table 2 Incremental increase in RFS at 5 years, in relation to dose intensity by axillary nodal status

From: The analysis of relapse-free survival curves: implications for evaluating intensive systemic adjuvant treatment regimens for breast cancer

 

Node negative

1–3 nodes

4–9 nodes

10+ nodes

Intermediate-dose intensity (7 log kill) vs standard therapy (2–4 logs)

2–5%

5–10%

8–14%

10–16%

High-dose intensity (9 log kill) vs intermediate-dose therapy (7 log kill)

<1%

1.5%

3.5%

8%

Back to article page